News

KREAXI TV

Press Release

Amolyt Pharma annonces research agreement and licensing option with XOMA

Amolyt Pharma (“Amolyt,” “Amolyt Pharma” or the “Company”), a global company specialized in developing innovative therapies for rare endocrine and related diseases, today announced that the Company has entered into a research agreement and licensing option with XOMA...